1.
Tacchetti C, Bagnato P, Locatelli A, Mazza D, Gaviraghi M, Castagnola P, Rabellino A, Daniele T. A comprehensive analysis of Trastuzumab-induced signaling suggests the role of HER2 in several cell processes and highlights alternative targets for HER2- positive breast cancer therapy. Ital J Anat Embryol [Internet]. 2015 Sep. 30 [cited 2024 Nov. 8];120(1):71. Available from: https://oajournals.fupress.net/index.php/ijae/article/view/4025